EVIA Life Sciences Inc.
Tokyo, US · 1 known investors
Find your way into EVIA Life Sciences Inc.
Sign up to see every warm intro you have to EVIA Life Sciences Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EVIA Life Sciences Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EVIA Life Sciences develops cell-free therapeutics based on extracellular vesicles derived from chemically induced liver progenitor cells, using a non-genetic cell reprogramming process. Its lead program targets liver fibrosis and MASH, and the company works with pharmaceutical and biotechnology partners.
Founders & leadership
KT
Kosuke TakishimaNamed on SEC filing
JR
Joshua Raphael SchwabNamed on SEC filing
MK
Michael KimNamed on SEC filing
TO
Takahiro OchiyaNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2026
▶$700KraisedNov 2026 · 1 investors · BiotechnologyRule 506(b)
▶$700KraisedNov 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kosuke TakishimaExecutive Officer
- Joshua Raphael SchwabDirector
- Michael KimDirector
- Takahiro OchiyaDirector
- Offering amount
- $5.5M
- Amount sold
- $700K
- First sale
- Oct 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does EVIA Life Sciences Inc. do?
- EVIA Life Sciences develops cell-free therapeutics based on extracellular vesicles derived from chemically induced liver progenitor cells, using a non-genetic cell reprogramming process. Its lead program targets liver fibrosis and MASH, and the company works with pharmaceutical and biotechnology partners.
- Who are EVIA Life Sciences Inc.'s investors?
- EVIA Life Sciences Inc.'s investors include Octave Ventures Llc.
- How much funding has EVIA Life Sciences Inc. raised?
- EVIA Life Sciences Inc. has disclosed $700K raised across 1 round.
- Where is EVIA Life Sciences Inc. headquartered?
- EVIA Life Sciences Inc. is headquartered in Tokyo, US.